Cellistic, a pioneer in iPSC-based off-the-shelf cell therapy development and manufacturing services, announces the launch of ...

Shares of Century Therapeutics, Inc. (NASDAQ:IPSC – Get Free Report) have received a consensus recommendation of “Buy” from ...

Stem cell therapy is emerging as a potential treatment for different conditions in endocrinology, including diabetes and ...

The global induced pluripotent stem cells market size is calculated at USD 2.13 billion in 2025 and is expected to reach ...

This is especially problematic in cases of blocked blood vessels, which can repeatedly starve large areas of the heart of ...

Three lines of GMP iPS Cells derived from type O female blood are now offered as off-the-shelf product It is well known that HLA homozygous iPSCs are often selected to reduce adverse immune ...

2025年2月13日，哈佛大学医学院的研究人员在 Cell 子刊 Cell Stem Cell 上发表了题为：Pre-clinical safety and efficacy of human induced pluripotent stem ...

Cellistic, a pioneer in iPSC-based off-the-shelf cell therapy development and manufacturing services, announces the launch of its Allo Chassis-ready-to-use, immune-cloaked iPSC cell lines derived from ...

帕金森病（Parkinson’s Disease，PD），是一种复杂的神经退行性疾病，也是世界上第二常见的神经退行性疾病，仅次于阿尔茨海默病（AD），影响着约 1?% 的 65 岁及以上老人。随着全球人口老龄化，帕金森病患病率还将大幅增加。 人诱导多能干细胞（hiPSC）来源的中脑多巴胺能细胞（mDAC）为帕金森病的自体细胞疗法提供了一个有前景的来源，但标准化的调控标准对于临床转化至关重要。 20 ...